**GENERIC SPECIALS - DEEP DISCOUNTS **
"Weekly Generics Campaign"
LOOK for DEEP Discounts with APCIÍs Weekly Generics Campaign!
Items on the Generics Campaign will run weekly
Items on the Generics Campaign this week:
Effective 3/12/15 – 3/18/15
| ITEM |
NDC NUM |
DSCR |
DISC % |
CAMPAIGN ORDERING DATES |
CAMPAIGN INVOICE DATES |
| 2462596 |
00781148801 |
AMITRIP TAB 50MG SAN 100@ * |
30% |
3/12/15 - 3/18/15 |
3/13/15 - 3/19/15 |
| 2048783 |
00115148361 |
DICLOFEN SOD GEL 3% GPC 100G@ * |
30% |
3/12/15 - 3/18/15 |
3/13/15 - 3/19/15 |
| 1772516 |
60505025202 |
TIZANIDINE TAB 4MG APX 1000@ * |
30% |
3/12/15 - 3/18/15 |
3/13/15 - 3/19/15 |
| 1179589 |
13925015903 |
LIDOCA 3% CRM SETO 3OZ@ * |
30% |
3/12/15 - 3/18/15 |
3/13/15 - 3/19/15 |
| 3418480 |
60505317007 |
OMEGA-3 ACD ETH CP 1GM APX120@ * |
30% |
3/12/15 - 3/18/15 |
3/13/15 - 3/19/15 |
| PLEASE NOTE - EXTENDED CAMPAIGN DUE TO PRICE LOAD DELAY |
| 3407699 |
00228285111 |
GUANFACINE HCL ER 2MG 100* |
25% |
3/4/15 -
3/18/15 |
3/05/15 -
3/19/15 |
* Special pricing on orders placed 3/12/15
– 3/18/15, invoiced on 3/13/15 – 3/19/15
Watch for these
Items on Generics Campaign NEXT week:
| ITEM # |
NDC |
DESC |
TOP 250 |
CAMPAIGN DATES |
INVOICE DATES |
DISC % |
| 2243475 |
65862052305 |
GABAPENTIN
600MG 500'S |
Y |
3/19/15 -
3/25/15 |
3/20/15 -
3/26/15 |
30% |
| 3254448 |
00093032101 |
DILTIAZAM
120MG 100'S |
N |
3/19/15 -
3/25/15 |
3/20/15 -
3/26/15 |
30% |
| 1811090 |
17478019030 |
LIDOCAINE/PRILOCAINE
2.5% -2.5% 30 |
Y |
3/19/15 -
3/25/15 |
3/20/15 -
3/26/15 |
30% |
| 1337328 |
00093208517 |
TRIAMCINOLONE
ACETONIDE 55MCG 16.5 |
Y |
3/19/15 -
3/25/15 |
3/20/15 -
3/26/15 |
30% |
| 2439149 |
10147092205 |
HALOPERIDOL
DEC |
N |
3/19/15 -
3/25/15 |
3/20/15 -
3/26/15 |
30% |
Check out a full list of Custom Discounted Items our website weekly - updated every Monday!
https://www.apcinet.com/AboutUs/Services/VendorContracting/APCIDiscountedGenerics/tabid/535/Default.aspx
McKesson OneStop Generics¨
Price Assurance Promotion – Price Alert
March 5, 2015
Please make note of the following items eligible for the Price Assurance Promotion:
| ITEM NUMBER |
NDC |
DESCRIPTION |
START DATE |
END DATE |
TOP MOVERS |
| 2474674 |
00093718856 |
FLUOXET TAB 10MG TEV 30 |
3/5/2015 |
4/4/2015 |
|
| 3000346 |
00093718810 |
FLUOXET HCL TAB 10MG TEV1000 |
3/5/2015 |
4/4/2015 |
|
McKesson has been notified of 1 product family representing 2 items that
increases in price on March 5, 2015. A customer's purchase of
these items will be covered by the Price Assurance Promotion for 30 days
following the price assurance start date.
Customers
will receive price assurance payments on purchases of eligible product during
the 30-day price assurance period, up to a maximum quantity determined by their
purchase history. Price assurance will be provided on the difference between
the new invoice price and the invoice price before the invoice price increase,
multiplied by the eligible quantity.
For more information, please visit the OneStop Generics homepage on McKesson Connect.
Note: The percentage increase in the invoice price may vary from the percentage increase in the WAC price
Launch Update
Based on published patent expiration dates and pending court decisions, the table below was constructed to highlight some anticipated high-volume, near-term launches. Upon launch, we expect to add these products to the McKesson OneStop Generics program.
| Product |
Generic Name |
Projected Launch Date(CY) |
Est. U.S. Brand Sales ($M) |
Launch Type |
| Lamictal ODT |
lamotrigine |
March 2015 |
70 |
E |
| Megace (5oz, 8oz) |
megestrol |
March 2015 |
48 |
MP |
| Actonel (5mg, 30mg, 35mg) |
risedronate sodium |
March 2015 |
210 |
CE |
| Transderm Scop |
scopolamine |
Q1 2015 |
60 |
TBD |
| Pulmicort (1mg) |
budesonide |
Q1 2015 |
120 |
TBD |
| Abilify |
aripiprazole |
4/20/2015 |
4656 |
TBD |
| Welchol (tablets) |
colesevelam hydrochloride |
April 2015 |
600 |
MP |
| Generess FE |
ethinyl estradiol, norethindrone |
April 2015 |
300 |
TBD |
| Namenda |
memantine HCl |
7/11/2015 |
2400 |
TBD |
| Welchol (powder) |
colesevelam hydrochloride |
July 2015 |
150 |
TBD |
MP = Multi-Player; E = Exclusive; CE = Co-Exclusive
All estimated launch dates are subject to change as a result of litigation and patent exclusivities. Patent expiration dates may not imply generic availability.
Recent Generic Launches
| Product |
Supplier(s) |
Launch Date (CY) |
Est. U.S. Brand Sales ($M) |
Launch Type |
| Tarka |
Glenmark; Greenstone (AG) |
2/26/2015 |
52 |
CE |
| Nexium capsules |
Teva |
2/17/2015 |
6250 |
E |
| Mirapex ER |
Par |
2/12/2015 |
60 |
E |
| Focalin ER (10mg) |
Sandoz |
2/3/2015 |
200 |
CE |
| Mitigare 505(b)(2) |
Westward (AG) |
1/16/2015 |
N/A |
E |
| Colcrys |
Prasco (AG) |
1/12/2015 |
238 |
E |
| Oxycontin |
Actavis (AG); Par; Sandoz |
1/6/2015 |
2730 |
MP |
| Zyvox Bags |
Teva |
1/5/2015 |
250 |
E |
| Clobex Spray |
Perrigo |
1/2/2015 |
103 |
E |
Pricing Update
Price Decreases for February 2015
McKesson has reduced pricing on the following high-volume product families:
| Product Family |
Avg Price Reduction* |
Family Rank** |
| ATORVASTATIN CALCIUM |
-17.9% |
32 |
| AMLODIPINE
BESYLATE/BENAZEPRIL |
-6.8% |
139 |
| AMLODIPINE BESYLATE |
-5.9% |
221 |
| TIZANIDINE HCL |
-5.4% |
37 |
| TEMOZOLOMIDE |
-4.7% |
154 |
| TRAMADOL HCL |
-4.6% |
134 |
| CEFUROXIME AXETIL |
-4.3% |
73 |
| PIOGLITAZONE
HCL/METFORMIN HCL |
-4.3% |
233 |
| VALSARTAN/HYDROCHLOROTHIAZIDE |
-4.3% |
219 |
| TRAZODONE HCL |
-4.2% |
213 |
| METHOTREXATE SODIUM |
-4.1% |
46 |
| ZIPRASIDONE HCL |
-3.6% |
114 |
| DULOXETINE HCL |
-3.6% |
20 |
| NYSTATIN |
-3.4% |
70 |
| VALACYCLOVIR HCL |
-3.3% |
112 |
| NIACIN |
-3.3% |
54 |
| BUDESONIDE |
-3.3% |
7 |
| SPIRONOLACTONE |
-3.0% |
201 |
| MYCOPHENOLATE SODIUM |
-2.8% |
64 |
| TACROLIMUS |
-2.7% |
42 |
| BUMETANIDE |
-2.7% |
163 |
| VORICONAZOLE |
-2.6% |
158 |
| AZELASTINE HCL |
-2.4% |
159 |
| VENLAFAXINE HCL |
-2.4% |
63 |
| NITROFURANTOIN
MONOHYD/M-CRYST |
-2.4% |
115 |
* Percentage change reflects the weighted average decrease of products in the family that received a price reduction. It includes
product switches but excludes adds and removals.
** Family rank is based on the selected time span.
Service Levels
OneStop Generics Service Level for the week ending February 27th: 89.9%, down 0.3% from prior week.
Please find the Service Level Watchlist Report, designed to provide an easily navigable reference for contemporary updates on OneStop items with inventory concerns. Furthermore, the document will allow for quick identification of alternate OneStop pack sizes and alternate OneStop manufacturers (AC position) that can be purchased in the interim.
|
NEWS YOU CAN USE - RUMOR HAS IT
|
The following info comes from a reliable source but cannot be guaranteed. Please use discretion when ordering based off of this info:
RED ALERT= price increase guaranteed.
HYDRALAZINE INJECTION- IN LINE TO TAKE A MAJOR INCREASE. THE 25 CTS LOOK TO BE SET TO
GO FROM THE $300 range to the $900 range
MESALAMINE RECTAL SUSPENSION [Rowasa]- The
increase looks to be towards the $115 range.
4g-60mL/7x60mL
BENZONATATE- One manufacturer has
announced a 300% increase, taking these to the $20 range on the 100mg, and $30
range on the 200mg.
PROPRANOLOL- [Inderal] tabs <<Over 800% increase. (New range will be more than double
these prices below!)
PRIMIDONE- [Mysoline] tabs <<50mg
80% increase, 250mg 130% increase (with significant shortages)
CARBIDOPA-LEVODOPA- [Sinemet] tabs <<50% increase
METHYLDOPA- [Aldomet] tabs <<90% increase
FAMOTIDINE- [Pepcid] tabs <<40% increase
NORTRIPTYLINE- [Pamelor] caps <<90% increase
CIPROFLOXACIN- [Cipro] tabs <<180% increase
on 500mg, no word on 250mg
BETHANECHOL- [Urecholine] tabs <<19%-36%
increase, depending on strength
ISONIAZID- tabs <<50% increase
ESTRADIOL- [Estrace] tabs <<90% increase
KETOPROFEN CAPS- 90%
increase
DILTIAZEM TABS- 90%
increase,
LIDOCAINE 4% SOLUTION- 2200% increase!
PENICILLIN SOLUTION- 90%
increase (not expensive though.)
DANAZOL- 90%
increase,
CARNITOR- 200mg/mL
solution 40% increase,
DEPO-MEDROL- Minor
increases across the board of around 12%,
YELLOW ALERT= substantial rumors of price increase, substantial recipe for market increase, dramatic shortages, allocations.
DESMOPRESSIN LIQUID- Rumor
is that a major wholesaler doubled their price,
DULOXETINE- [Cymbalta] caps- There are some shortages, that seem to be
growing. Some manufacturers are experiencing raw material issues.
Others eventually wonÕt be able to keep up. I am being told
by a substantial manufacturer, it will be AT LEAST a month until they
can get us more.
OLANZAPINE- [Zyprexa] tabs- Rumors that the plain is taking an increase, No word of
potential range. On backorder when these sell out! I am seeing some major
supply issues with these!
GLIMEPIRIDE- [Amaryl] tabs- Rumors and evidence that
manufacturers that didnÕt previously increase, are now catching up. Some
are in the $13-$20 range at best, as a new, settled price range.
ESCITALOPRAM- [Lexapro] tabs- Rumors starting back up that the
increase is near. I am seeing a number of manufacturing issues on multiple
manufacturers.
TACROLIMUS- [Prograf] caps- Keep your eye out on this one still. This could
be one of those that happens months after initial
speculation. To me it now seems that the manufacturer that was having
issues, seems to have buttoned them up, at least temporarily.
VITAMIN D- [Drisdol, Ergocalciferol]
caps- Rising has
discontinued manufacturing this product, no clue on the market impact this will
have yet, except that I can say that at one time Rising was a number of
companyÕs primary manufacturers. There are a decent number of
manufacturers, so it is likely not a 10 fold increase
probability (if at all,) but there may be shortages due to other manufacturers
trying to keep up with supply.
RISPERIDONE- [Risperdal] tabs- Qualitest has discontinued manufacturing this
product, no clue on the market impact this will have. Qualitest is a substantial manufacturer, but there are many on this product, so it is
likely not a 10 fold increase probability (if at all,)
but there may be shortages due to other manufacturers trying to keep up with
supply. <<THESE ARE STARTING TO
SELL OUT DUE TO QUALITEST DISCONTINUATION
PRAMIPEXOLE- [Mirapex] tabs-Aurobindo has discontinued manufacturing this
product, no clue on the market impact this will have. There are many
manufacturers of this product, but I can say, one major wholesaler has seemed
to have increase around $10 on these
PENICILLIN VK- [Veetids] tabs- Greenstone has discontinued, no clue on the market
impact this will have. There are plenty of manufacturers on this, but
some have increased
PYRIDOSTIGMINE BROM- Price increased announced to happen within a month,
new range not currently known. It doesnÕt appear to be a MAJOR increase,
but even with minor increases the potential is still close to double.
NITROGLYCERIN SPRAY- In line to take an increase, no word of range yet!
OXCARBAZEPINE- 250%-300% increase expected for over 6 months, on
the verge of happening
PHENYTOIN ER 100mg- A major wholesaler has announced that
one of their manufacturers will be raising their price to $533 on the 1000ct.
PENICILLIN VK- taking a major
increase from one manufacturer. We shall see if the others follow suit.
BACTRIM
Tablets- supposed to double.
DESMOPRESSIN tabs- RUMORS
OF INCREASE, REPORTED INCREASES. Reports are about 5 fold.
GABAPENTIN- 600mg and 800mg
tabs, some manufacturers are trying to increase, others resisting, some supply
issues, resistance likely wonÕt stand for long.
APCI Approved Vendors
In the event that you will be returning 2014-15 Novartis products, here
are the necessary steps to complete the process.
For the 2014-15 season, up to 30% of
each Novartis product presentation ordered direct from FFF and listed
below are eligible for return for the full purchase price as a credit to be
applied to account:
- Fluvirin 5mL 10-dose
vial
- Fluvirin 0.5mL prefilled
syringes, needleless, 10 per box
- Flucelvax 0.5mL
prefilled syringes, needleless, 10 per box
Full 10-dose vials and boxes of 10 prefilled
syringes must be in their original unopened cartons.
RETURN DATES
Novartis returns
will be accepted by FFF Enterprises starting Wednesday, February 18,
2015 but no later than Wednesday, March 18, 2015.
RETURN OF GOODS AUTHORIZATION
To ensure a successful
return process, you MUST first request a Return Goods Authorization (RGA)
number by following one of the options listed below:
Please let us know the lot numbers of the products
you wish to return. Also indicate the fax number or email address where the RGA
should be sent.
Important: Returns cannot be accepted without this
RGA number!
SHIPPING
Customers are responsible for arranging and paying
for shipping eligible return product to FFF Enterprises.
No refrigerated packaging is required, however all
product must be properly packaged so that it will not be damaged during
transit.
NOVARTIS INFLUENZA VACCINE ONLY
This information applies
to the Novartis lnfluenza Virus Vaccine for
the 2014-15 season only.
Information and guidelines for return of all other
brands of influenza vaccine for the 2014-2015 season will be provided in other
communications.
Please remember the deadline for returning
Novartis influenza vaccines to FFF is Wednesday, March 18, 2015.
If you have questions, please contact Wow! Customer Care at (800) 843-7477.
Welcome New Neighbor
Please click on the image below to open a printable version in a new window.